Approval · Notice of Compliance 27172 · 2021
STRESNIL: Notice of Compliance 27172
Issued December 6, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27172
- Date
- December 6, 2021
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing and testing site - drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STRESNIL | 00755710 | Marketed |
Medicinal ingredients
- AZAPERONE 40 MG per ML